|
業務類別
|
Drug Manufacturers - Specialty & Generic |
|
業務概覽
|
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services. |
| 公司地址
| 31 East 62nd Street, New York, NY, USA, 10065 |
| 電話號碼
| +1 212 672-9100 |
| 傳真號碼
| +1 212 697-3130 |
| 公司網頁
| https://www.siga.com |
| 員工數量
| 49 |
| Dr. Dennis E. Hruby,PhD |
Executive Vice President and Chief Scientific Officer |
美元 748.53K |
28/04/2026 |
| Mr. Daniel J. Luckshire |
Executive Vice President, Chief Financial Officer and Principal Accounting Officer |
美元 752.25K |
28/04/2026 |
| Mr. Lawrence R. Miller |
General Counsel and Corporate Secretary |
美元 695.25K |
28/04/2026 |
| Dr. Diem Nguyen, M.B.A.,PhD |
Chief Executive Officer and Director |
美元 927.00K |
28/04/2026 |
|
|
| General John M. Keane, (Ret.) |
Independent Director |
28/04/2026 |
| Mr. Jaymie A. Durnan |
Independent Director |
28/04/2026 |
| Mr. Joseph W. Marshall, III |
Independent Director |
28/04/2026 |
| Mr. Harold E. Ford, Jr |
Independent Director |
28/04/2026 |
| Dr. Diem Nguyen, M.B.A.,PhD |
Chief Executive Officer and Director |
28/04/2026 |
| Mr. Julian Nemirovsky |
Independent Director |
28/04/2026 |
| Dr. Gary J. Nabel, M.D.,PhD |
Independent Director |
28/04/2026 |
| Dr. Holly L. Phillips, M.D. |
Independent Director |
28/04/2026 |
|
|
|
|
